Waheed S Ibrahimi, MD
Internal Medicine · San Ramon
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 29
- 8 carriers
- Office
- 1
- Since medical school
- 20 years
- Graduated 2006
Offices
1 location
Looking this up.
Plans that list them
29 plans · 8 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Ibrahimi’s office at (925) 365-7337 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
29 of 29 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A128575 · Current
Licensed to practise in California · since 2014 · expires 2027-07-31 · Ross University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$17,591
Medicare paid this office $17,591 for 35 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 25 | $6,823 | $116 |
| Long return visit (40+ min) | 17 | $5,117 | $160 |
| New patient visit (45+ min) | 17 | $2,352 | $138 |
Who their Medicare patients are
35 Original Medicare patients in 2024. Average age 72 · Women 60% · Health risk score 1.07. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 74% · Depression 40% · Diabetes 37%.
The office billed $149,890, Medicare allowed $23,584 and paid $17,591; for 151 services of 11 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 35 | 151 | 72 | 1.07 | $149,890 | $17,591 |
| 2017 | 72 | 185 | 81 | 2.54 | $51,965 | $16,607 |
| 2016 | 318 | 1,027 | 77 | 2.36 | $342,309 | $92,887 |
| 2015 | 146 | 422 | 76 | 2.26 | $136,734 | $36,081 |
| 2014 | 214 | 644 | 70 | 2.45 | $128,952 | $46,785 |
| 2013 | 164 | 492 | 72 | 2.52 | $72,917 | $30,204 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2017: 3 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 47 | $8,268 | $89 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 25 | $3,234 | $62 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $2,437 | $174 |
2016: 10 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 203 | $42,803 | $89 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 115 | $13,252 | $62 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 54 | $9,581 | $174 |
| Hospital discharge day management, more than 30 minutes | 89 | $8,450 | $93 |
| Critical care, first 30-74 minutes | 17 | $5,502 | $190 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 42 | $4,752 | $113 |
| Hospital discharge day management, 30 minutes or less | 24 | $1,524 | $64 |
| Initial hospital observation care per day, typically 50 minutes | 12 | $1,402 | $117 |
| Follow-up observation care per day, typically 25 minutes | 11 | $930 | $62 |
| Hospital observation care on day of discharge | 12 | $750 | $62 |
2015: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 83 | $15,614 | $88 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 66 | $6,791 | $61 |
| Hospital discharge day management, more than 30 minutes | 41 | $3,849 | $92 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 28 | $3,487 | $112 |
| Hospital discharge day management, 30 minutes or less | 17 | $1,074 | $63 |
2014: 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 99 | $15,674 | $82 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 135 | $14,983 | $56 |
| Hospital discharge day management, more than 30 minutes | 50 | $4,357 | $84 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 38 | $4,241 | $109 |
| Hospital discharge day management, 30 minutes or less | 36 | $2,005 | $56 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $1,751 | $159 |
| Follow-up observation care per day, typically 25 minutes | 13 | $851 | $57 |
| Hospital observation care on day of discharge | 15 | $850 | $57 |
2013: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 121 | $13,428 | $51 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 73 | $8,850 | $76 |
| Hospital discharge day management, more than 30 minutes | 55 | $4,603 | $78 |
| Hospital discharge day management, 30 minutes or less | 11 | $609 | $55 |
Medicaid work
$103,464 in 2024
Medicaid paid $103,464 for 773 billed services this clinician did in 2024, up to 67 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 425 | $48,419 |
| Long return visit (40+ min) | 187 | $29,034 |
| New patient visit (45+ min) | 91 | $13,814 |
| New patient visit (60+ min) | 70 | $12,197 |
| 2024 | 773 | 4 | 67 | $103,464 |
Drugs they prescribed that Part D paid
$18,145
Pharmacies billed $18,145 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
283 generic and fewer than 11 brand-name prescriptions · $18,145 in drug cost · 21 antibiotic prescriptions to 14 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Atorvastatin | 35 | $256 | $7 |
| Amlodipine Besylate | 26 | $82 | $3 |
| Metformin | 13 | $43 | $3 |
Year by year
| 2024 | 304 | 48 | None | None | $18,145 |
| 2023 | 56 | 13 | 0% (0) | None | $4,220 |
| 2022 | 16 | None | 0% (0) | None | $6,091 |
| 2017 | 67 | 24 | None | None | $3,308 |
| 2016 | 133 | 65 | None | None | $3,987 |
| 2015 | 57 | 28 | None | 21% | $2,983 |
| 2014 | 170 | 92 | None | None | $7,686 |
| 2013 | 274 | 116 | 6% (16) | None | $12,407 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2014: 1 drug
| Levofloxacin | 15 | $181 | $12 |
2013: 5 drugs
| Clopidogrel | 12 | $299 | $25 |
| Ciprofloxacin | 12 | $69 | $6 |
| Metoprolol | 16 | $62 | $4 |
| Prednisone | 17 | $58 | $3 |
| Lisinopril | 11 | $46 | $4 |
Money from drug and device companies
$3,159 in 2025
| 2025 | 28 | 133 | None | $3,159 |
| 2024 | 19 | 54 | None | $1,488 |
| 2023 | 17 | 39 | None | $855 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Neurocrine BioSciences | Ingrezza | $652 | 20 payments
|
| SK Life Science | None | $382 | 24 payments
|
| Ucb | Briviact | $314 | 13 payments
|
| Abbvie | Ubrelvy | $289 | 14 payments
|
| CSL Behring | Hizentra | $251 | 8 payments
|
| Otsuka America Pharmaceutical | Rexulti | $209 | 8 payments
|
See all 133 published payments
| SK Life Science | Meals · 2025-12-24 | None | $19 |
| SK Life Science | Meals · 2025-12-23 | None | $0 |
| CSL Behring | Meals · 2025-12-22 | Hizentra | $24 |
| Pfizer | Meals · 2025-12-19 | Nurtec Odt | $5 |
| Aucta Pharmaceuticals | Meals · 2025-12-19 | Motpoly Xr | $22 |
| Neurocrine BioSciences | Meals · 2025-12-17 | Ingrezza | $39 |
| CSL Behring | Meals · 2025-12-12 | Hizentra | $28 |
| Abbvie | Meals · 2025-12-11 | Qulipta | $29 |
| Globus Medical | Meals · 2025-12-09 | Senza | $23 |
| Ucb | Meals · 2025-12-04 | Fintepla | $2 |
| Ucb | Meals · 2025-12-04 | Fintepla | $25 |
| Ucb | Meals · 2025-12-03 | Nayzilam | $22 |
| Otsuka America Pharmaceutical | Meals · 2025-12-03 | Rexulti | $33 |
| Ge Healthcare | Meals · 2025-12-02 | None | $15 |
| Aucta Pharmaceuticals | Meals · 2025-11-26 | Motpoly Xr | $25 |
| Merz Pharmaceuticals | Meals · 2025-11-25 | Inbrija | $29 |
| SK Life Science | Meals · 2025-11-24 | None | $33 |
| Pfizer | Meals · 2025-11-21 | Nurtec Odt | $22 |
| Neurocrine BioSciences | Meals · 2025-11-19 | Ingrezza | $37 |
| Neurocrine BioSciences | Meals · 2025-11-19 | Ingrezza | $2 |
| SK Life Science | Meals · 2025-11-13 | None | $34 |
| Ucb | Meals · 2025-11-11 | Nayzilam | $30 |
| Axsome Therapeutics | Meals · 2025-11-11 | Symbravo | $13 |
| Jazz Pharmaceuticals | Meals · 2025-11-07 | Epidiolex | $17 |
| Lundbeck | Meals · 2025-11-06 | Rexulti | $31 |
| Abbvie | Meals · 2025-10-31 | Qulipta | $24 |
| Ucb | Meals · 2025-10-30 | Fintepla | $1 |
| Ucb | Meals · 2025-10-30 | Fintepla | $24 |
| SK Life Science | Meals · 2025-10-28 | None | $11 |
| Neurocrine BioSciences | Meals · 2025-10-24 | Ingrezza | $38 |
| SK Life Science | Meals · 2025-10-24 | None | $16 |
| Neurocrine BioSciences | Meals · 2025-10-23 | Ingrezza | $0 |
| CSL Behring | Meals · 2025-10-20 | Hizentra | $22 |
| Teva Pharmaceuticals USA | Meals · 2025-10-15 | Austedo Xr | $31 |
| Exact Sciences | Meals · 2025-10-13 | The Cologuard Plus Collection Kit | $29 |
| Novo Nordisk | Meals · 2025-10-11 | Wegovy | $23 |
| SK Life Science | Meals · 2025-10-09 | None | $25 |
| Ucb | Meals · 2025-10-08 | Briviact | $25 |
| Otsuka America Pharmaceutical | Meals · 2025-10-05 | Rexulti | $27 |
| Lundbeck | Meals · 2025-10-03 | Rexulti | $33 |
| Abbvie | Meals · 2025-10-02 | Ubrelvy | $31 |
| Aucta Pharmaceuticals | Meals · 2025-09-30 | Motpoly Xr | $23 |
| Ge Healthcare | Meals · 2025-09-26 | None | $17 |
| SK Life Science | Meals · 2025-09-26 | None | $21 |
| CSL Behring | Meals · 2025-09-22 | Hizentra | $21 |
| Abbvie | Meals · 2025-09-12 | Qulipta | $18 |
| SK Life Science | Meals · 2025-09-11 | None | $26 |
| Janssen Pharmaceuticals | Meals · 2025-09-09 | Invega Sustenna | $19 |
| Ucb | Meals · 2025-09-05 | Fintepla | $2 |
| Pfizer | Meals · 2025-08-29 | Nurtec Odt | $22 |
| Neurocrine BioSciences | Meals · 2025-08-29 | Ingrezza | $31 |
| Novo Nordisk | Meals · 2025-08-27 | Ozempic | $14 |
| Jazz Pharmaceuticals | Meals · 2025-08-26 | Epidiolex | $19 |
| Biogen | Meals · 2025-08-25 | Zurzuvae | $24 |
| Merz Pharmaceuticals | Meals · 2025-08-25 | Inbrija | $37 |
| Abbvie | Meals · 2025-08-23 | Ubrelvy | $29 |
| Neurocrine BioSciences | Meals · 2025-08-20 | Ingrezza | $36 |
| SK Life Science | Meals · 2025-08-20 | None | $14 |
| SK Life Science | Meals · 2025-08-20 | None | $1 |
| Otsuka America Pharmaceutical | Meals · 2025-08-18 | Rexulti | $30 |
| CSL Behring | Meals · 2025-08-18 | Hizentra | $40 |
| Abbvie | Meals · 2025-08-16 | Qulipta | $26 |
| SK Life Science | Meals · 2025-08-12 | None | $30 |
| Lilly USA | Meals · 2025-08-11 | Mounjaro | $30 |
| Teva Pharmaceuticals USA | Meals · 2025-08-08 | Austedo Xr | $24 |
| Abbvie | Meals · 2025-08-05 | Ubrelvy | $26 |
| Axsome Therapeutics | Meals · 2025-08-04 | Symbravo | $25 |
| Jazz Pharmaceuticals | Meals · 2025-07-30 | Epidiolex | $24 |
| Neurocrine BioSciences | Meals · 2025-07-28 | Ingrezza | $31 |
| SK Life Science | Meals · 2025-07-24 | None | $11 |
| Ucb | Meals · 2025-07-22 | Fintepla | $21 |
| Abbvie | Meals · 2025-07-18 | Qulipta | $25 |
| Otsuka America Pharmaceutical | Meals · 2025-07-15 | Rexulti | $28 |
| CSL Behring | Meals · 2025-07-14 | Hizentra | $41 |
| Aucta Pharmaceuticals | Meals · 2025-07-02 | Motpoly Xr | $23 |
| Abbvie | Meals · 2025-06-30 | Ubrelvy | $3 |
| Axsome Therapeutics | Meals · 2025-06-30 | Symbravo | $28 |
| Abbvie | Meals · 2025-06-24 | Ubrelvy | $28 |
| Pfizer | Meals · 2025-06-20 | Nurtec Odt | $21 |
| SK Life Science | Meals · 2025-06-17 | None | $31 |
| Otsuka America Pharmaceutical | Meals · 2025-06-10 | Rexulti | $14 |
| Neurocrine BioSciences | Meals · 2025-06-10 | Ingrezza | $130 |
| Otsuka America Pharmaceutical | Meals · 2025-06-08 | Rexulti | $29 |
| Alkermes | Meals · 2025-06-07 | Aristada | $23 |
| SK Life Science | Meals · 2025-06-05 | None | $15 |
| SK Life Science | Meals · 2025-06-05 | None | $1 |
| Insulet | Meals · 2025-06-04 | Omnipod | $25 |
| Indivior | Meals · 2025-06-04 | Sublocade | $22 |
| Neurocrine BioSciences | Meals · 2025-05-30 | Ingrezza | $40 |
| Ucb | Meals · 2025-05-28 | Briviact | $38 |
| SK Life Science | Meals · 2025-05-27 | None | $8 |
| CSL Behring | Meals · 2025-05-23 | Hizentra | $39 |
| Otsuka America Pharmaceutical | Meals · 2025-05-21 | Rexulti | $21 |
| Neurocrine BioSciences | Meals · 2025-05-17 | Ingrezza | $39 |
| Teva Pharmaceuticals USA | Meals · 2025-05-15 | Austedo Xr | $24 |
| CSL Behring | Meals · 2025-05-10 | Hizentra | $35 |
| GlaxoSmithKline | Meals · 2025-05-09 | Shingrix | $22 |
| Celgene | Meals · 2025-04-28 | Zeposia | $26 |
| Bausch Health US | Meals · 2025-04-22 | Aplenzin | $20 |
| Neurocrine BioSciences | Meals · 2025-04-22 | Ingrezza | $28 |
| Abbvie | Meals · 2025-04-18 | Ubrelvy | $15 |
| Pfizer | Meals · 2025-04-18 | Nurtec Odt | $26 |
| Neurocrine BioSciences | Meals · 2025-04-18 | Ingrezza | $37 |
| Ucb | Meals · 2025-03-28 | Rystiggo | $46 |
| Teva Pharmaceuticals USA | Meals · 2025-03-25 | Austedo Xr | $27 |
| Abbvie | Meals · 2025-03-24 | Ubrelvy | $17 |
| Aucta Pharmaceuticals | Meals · 2025-03-21 | Motpoly Xr | $23 |
| Abbvie | Meals · 2025-03-18 | Qulipta | $11 |
| SK Life Science | Meals · 2025-03-13 | None | $23 |
| Neurocrine BioSciences | Meals · 2025-03-12 | Ingrezza | $39 |
| Abbvie | Meals · 2025-03-11 | Qulipta | $6 |
| Pfizer | Meals · 2025-03-08 | Nurtec Odt | $17 |
| Tanabe Pharma America | Meals · 2025-03-04 | Radicava | $28 |
| Neurocrine BioSciences | Meals · 2025-03-01 | Ingrezza | $39 |
| Phadia US | Meals · 2025-02-26 | Immunocap | $14 |
| Celgene | Meals · 2025-02-18 | Zeposia | $20 |
| SK Life Science | Meals · 2025-02-18 | None | $18 |
| SK Life Science | Meals · 2025-02-18 | None | $4 |
| Ucb | Meals · 2025-02-11 | Briviact | $38 |
| Pfizer | Meals · 2025-02-04 | Nurtec Odt | $27 |
| Neurocrine BioSciences | Meals · 2025-01-31 | Ingrezza | $38 |
| SK Life Science | Meals · 2025-01-30 | None | $2 |
| SK Life Science | Meals · 2025-01-30 | None | $6 |
| SK Life Science | Meals · 2025-01-30 | None | $6 |
| Otsuka America Pharmaceutical | Meals · 2025-01-28 | Rexulti | $27 |
| Neurocrine BioSciences | Meals · 2025-01-22 | Ingrezza | $28 |
| Aucta Pharmaceuticals | Meals · 2025-01-21 | Motpoly Xr | $27 |
| Neurocrine BioSciences | Meals · 2025-01-17 | Ingrezza | $7 |
| Neurocrine BioSciences | Meals · 2025-01-17 | Ingrezza | $7 |
| Neurocrine BioSciences | Meals · 2025-01-17 | Ingrezza | $6 |
| Ge Healthcare | Meals · 2025-01-14 | None | $21 |
| Ucb | Meals · 2025-01-07 | Briviact | $40 |
| SK Life Science | Meals · 2025-01-07 | None | $26 |
See earlier years (2024, 2023)
2024: $1,488
| Neurocrine Biosciences | Ingrezza | $333 | 9 payments
|
| Ucb | Briviact | $219 | 6 payments
|
| Lilly USA | Mounjaro | $182 | 8 payments
|
| SK Life Science | None | $98 | 5 payments
|
| Acorda Therapeutics | Inbrija | $77 | 3 payments
|
| Otsuka America Pharmaceutical | Nuedexta | $76 | 3 payments
|
| Indivior | Sublocade | $69 | 2 payments
|
| Mitsubishi Tanabe Pharma America | Radicava | $63 | 2 payments
|
| Ge Healthcare | None | $60 | 3 payments
|
| Abbvie | Ubrelvy | $52 | 2 payments
|
| Teva Pharmaceuticals USA | Austedo Xr | $43 | 2 payments
|
| Aucta Pharmaceuticals | Motpoly Xr | $34 | 2 payments
|
| Pfizer | Nurtec Odt | $28 | 1 payment
|
| Tris Pharma | Dyanavel Xr | $27 | 1 payment
|
| Sumitomo Pharma America | Aptiom | $26 | 1 payment
|
| Biogen | Tysabri | $26 | 1 payment
|
| Octapharma USA | Panzyga | $25 | 1 payment
|
| Averitas Pharma | Qutenza | $25 | 1 payment
|
| Eisai | Leqembi | $25 | 1 payment
|
2023: $855
| Lilly USA | Amyvid | $128 | 9 payments
|
| Teva Pharmaceuticals USA | Austedo Xr | $88 | 3 payments
|
| Acorda Therapeutics | Inbrija | $75 | 3 payments
|
| Sumitomo Pharma America | Aptiom | $73 | 4 payments
|
| Octapharma USA | Panzyga | $66 | 3 payments
|
| Scilex Pharmaceuticals | Ztlido | $60 | 3 payments
|
| Abbvie | Ubrelvy | $57 | 2 payments
|
| Currax Pharmaceuticals | Onzetra Xsail | $53 | 3 payments
|
| Ucb | Briviact | $42 | 1 payment
|
| Neurocrine Biosciences | Ongentys | $40 | 1 payment
|
| SK Life Science | None | $32 | 1 payment
|
| Ipsen Biopharmaceuticals | Dysport | $32 | 1 payment
|
| Otsuka America Pharmaceutical | Rexulti | $29 | 1 payment
|
| Biogen | Tysabri | $28 | 1 payment
|
| Amneal Pharmaceuticals | Rytary | $24 | 1 payment
|
| Idorsia Pharmaceuticals US | Quviviq | $17 | 1 payment
|
| Mitsubishi Tanabe Pharma America | Radicava | $13 | 1 payment
|
Professional record
- NPI
- 1174716583
- Licence
- AZ 42035, CA A128575California A128575: Current · expires 2027-07-31
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- AZ 453891
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 4847 Hopyard Rd, Suite 4411, Pleasanton, CA, 94588
- NPI first listed
- 2007-08-20
- NPI last updated
- 2023-04-17
- NPI record certified
- 2023-04-17
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 175 N Jackson Ave Ste 202, San Jose, CA, 95116